We are live on ! Find out more
ICCM icon

IceCure Medical

8 hedge funds and large institutions have $85.3K invested in IceCure Medical in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

11% less funds holding

Funds holding: 98 (-1)

51% less capital invested

Capital invested by funds: $174K → $85.3K (-$89.1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

ICCM Hedge Fund Activity: Q3 2022 in Review

8 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q3 2022, worth a combined $85.3K — down 51% from $174K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ICCM and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.

The largest buyer was Bank of America, adding an estimated $14.2K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $78K sold.

  • 8 institutional investors held IceCure Medical (ICCM) as of Q3 2022, down from 9 in Q2 2022.
  • Funds reported $85.3K of IceCure Medical stock for Q3 2022, down 51% quarter-over-quarter.
  • 0 funds opened new IceCure Medical positions in Q3 2022 and 1 closed out, a net change of -1 holder.
  • The largest IceCure Medical buyer in Q3 2022 was Bank of America, an estimated $14.2K added.
  • The largest IceCure Medical seller in Q3 2022 was JP Morgan Chase, an estimated $78K sold.

Based on aggregated 13F filings for Q3 2022.